Clinical Trial

Association of Heart Failure Aggravation and Device-based Sensor Parameters

Study acronym: Heartlogic
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, observational patient registry designed to evaluate the association between changes in device-based sensor parameters and heart failure (HF) aggravation in patients implanted with Boston Scientific implantable cardioverter-defibrillators (ICDs) or cardiac resynchronization therapy defibrillators (CRT-Ds) equipped with HeartLogic™, Sleep Incline, and Apnea Scan functions. The study will prospectively collect remote monitoring and clinical follow-up data to determine whether changes in individual or combined device-based sensor parameters are associated with worsening HF events and to evaluate the clinical utility of remote monitoring for HF management.
Trial Details
NCT Number NCT07753135
Lead Sponsor Samsung Medical Center
Conditions Heart Failure, Cardiomyopathy
Enrollment 500 participants
Start Date 2023-02-01
Primary Completion 2027-08-08 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-07